Data as of Jul 30
| +0.06 / +1.33%|
The 5 analysts offering 12-month price forecasts for Novavax Inc have a median target of 11.00, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +141.23% increase from the last price of 4.56.
The current consensus among 5 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.